A new type 3 attenuated poliovirus for possible use in oral poliovirus vaccine.
D000818:Animals; D000917:Antibody Formation; D014644:Genetic Variation; D005827:Genetics, Microbial; D000882:Haplorhini; D006801:Humans; D007114:Immunization; D009154:Mutation; D009500:Neutralization Tests; D010600:Pharmacology; D011051:Poliomyelitis / Q000276:immunology; D017955:Poliovirus / Q000254:growth & development / Q000302:isolation & purification / Q000378:metabolism / Q000472:pathogenicity; D011055:Poliovirus Vaccine, Oral; D013696:Temperature; D014774:Virulence
D011055:Poliovirus Vaccine, Oral